Aurora Financial JournalThor Medical ASA (TRMED.OL)
Oslo Børs · Financial statements, TTM figures and earnings dates
Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| NOK | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 | FY2020 2020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | – | NOK 0 | NOK 0 | NOK 0 | NOK 0 |
| Operating income | −NOK 43.9M | −NOK 7.2M | NOK 0 | −NOK 442.4M | −NOK 434.2M |
| Net income | −NOK 42.2M | −NOK 29.1M | −NOK 307.1M | −NOK 441.3M | −NOK 417.1M |
| Diluted EPS | −NOK 0.18 | −NOK 0.15 | −NOK 2.70 | −NOK 4.65 | −NOK 5.99 |
| Cash flow | |||||
| Operating cash flow | −NOK 24.0M | −NOK 64.1M | −NOK 409.1M | −NOK 403.5M | −NOK 398.2M |
| Capital expenditure | NOK 140.0K | NOK 0 | NOK 5.6M | NOK 259.0K | NOK 185.0K |
| Free cash flow | −NOK 24.1M | −NOK 64.1M | −NOK 414.7M | −NOK 403.7M | −NOK 398.4M |
| Balance sheet | |||||
| Cash and equivalents | NOK 123.4M | NOK 41.8M | NOK 98.7M | NOK 277.7M | NOK 294.0M |
| Total assets | NOK 414.4M | NOK 330.8M | NOK 109.6M | NOK 296.7M | NOK 314.6M |
| Total liabilities | NOK 77.2M | NOK 58.9M | NOK 45.8M | NOK 156.2M | NOK 135.9M |
| Shareholders' equity | NOK 337.1M | NOK 271.9M | NOK 63.8M | NOK 140.5M | NOK 178.7M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in NOK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full TRMED.OL page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open TRMED.OL financials →